The percentage of CD68+ macrophages was decreased in the released patients with CML-CP (19.73 ± 3.43)%, CML-AP (25.77 ± 4.83)%, and CML-BP (43.49 ± 4.80)%, respectively. This evidence concerns the gene CD68 and alkaline phosphatase measurement.